Join to view full profile
6400 Fannin StSte 2900Houston, TX 77030
Phone+1 713-704-3961
Fax+1 713-704-3150
Dr. Cen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Putao Cen, based in Houston, Texas, has a focus in Oncology, with subspecialties in Gastrointestinal Cancer and Hematologic Oncology. She completed her medical education at Sun Yat-Sen University of Medical Science before undertaking multiple residencies in Internal Medicine at George Washington University, Icahn School of Medicine, and the Graduate Hospital. She also undertook a fellowship in Hematology and Medical Oncology at the University of Texas Health Science Center. Her research contributions include several publications in renowned journals, with numerous citations, and clinical trials studying G-202 (Mipsagargin). Dr. Cen's excellence in her field has been recognized with a Regional Top Doctor award from Castle Connolly in 2014.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Graduate HospitalResidency, Internal Medicine, 2004 - 2005
George Washington UniversityResidency, Internal Medicine, 2003 - 2003
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2002 - 2003
Sun Yat-Sen University of Medical ScienceClass of 1999
Certifications & Licensure
TX State Medical License 2007 - 2026
FL State Medical License 2009 - 2023
CA State Medical License 2008 - 2019
PA State Medical License 2004 - 2005
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Serial Thermal Ablation Induces Abscopal Antitumor Immunity and Reveals Targetable CSF1R-Dependent Resistance in Pancreatic Cancer.Lincoln N Strickland, Wendao Liu, MacKenzie V Demmel, Alyssa M Waller, Shwetapadma Dash
Biorxiv. 2026-04-08 - Comparative Effectiveness of Radiofrequency or Microwave Ablation and Chemotherapy for the Treatment of Large (>5 cm) Hepatocellular Carcinoma Tumors.Artem Boyev, Nirav Thosani, Putao Cen, Jennifer M Bailey-Lundberg, Julie Rowe
Cureus. 2026-04-01 - Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation.Kok Hoe Chan, Putao Cen, Tung Shu, Steven Canfield, Hui Zhao
The Journal of International Medical Research. 2026-03-01
Press Mentions
Colon Cancer Striking Younger PatientsApril 4th, 2019
Doctors Say Colon Cancer in Young People RisingApril 4th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
